Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by mollevi
Group name EquipeMY
Item Type Journal Article
Title The performance of PI-RADSv2 and quantitative apparent diffusion coefficient for predicting confirmatory prostate biopsy findings in patients considered for active surveillance of prostate cancer
Creator Nougaret et al.
Author Stephanie Nougaret
Author Nicola Robertson
Author Jennifer Golia Pernicka
Author Nicolas Molinari
Author Andreas M. Hötker
Author Behfar Ehdaie
Author Evis Sala
Author Hedvig Hricak
Author Hebert Alberto Vargas
Abstract PURPOSE: To assess the performance of the updated Prostate Imaging Reporting and Data System (PI-RADSv2) and the apparent diffusion coefficient (ADC) for predicting confirmatory biopsy results in patients considered for active surveillance of prostate cancer (PCA). METHODS: IRB-approved, retrospective study of 371 consecutive men with clinically low-risk PCA (initial biopsy Gleason score ?6, prostate-specific antigen <10 ng/ml, clinical stage ?T2a) who underwent 3T-prostate MRI before confirmatory biopsy. Two independent radiologists recorded the PI-RADSv2 scores and measured the corresponding ADC values in each patient. A composite score was generated to assess the performance of combining PI-RADSv2 + ADC. RESULTS: PCA was upgraded on confirmatory biopsy in 107/371 (29%) patients. Inter-reader agreement was substantial (PI-RADSv2: k = 0.73; 95% CI [0.66-0.80]; ADC: r = 0.74; 95% CI [0.69-0.79]). Accuracies, sensitivities, specificities, positive predicted value and negative predicted value of PI-RADSv2 were 85, 89, 83, 68, 95 and 78, 82, 76, 58, 91% for ADC. PI-RADSv2 accuracy was significantly higher than that of ADC for predicting biopsy upgrade (p = 0.014). The combined PI-RADSv2 + ADC composite score did not perform better than PI-RADSv2 alone. Obviating biopsy in patients with PI-RADSv2 score ?3 would have missed Gleason Score upgrade in 12/232 (5%) of patients. CONCLUSION: PI-RADSv2 was superior to ADC measurements for predicting PCA upgrading on confirmatory biopsy.
Publication Abdominal Radiology (New York)
Volume 42
Issue 7
Pages 1968-1974
Date 07 2017
Journal Abbr Abdom Radiol (NY)
Language eng
DOI 10.1007/s00261-017-1086-7
ISSN 2366-0058
Library Catalog PubMed
Extra PMID: 28258355 PMCID: PMC5537601
Tags Adult, Aged, Aged, 80 and over, Biopsy, clinic, Confirmatory, Contrast Media, Diffusion Magnetic Resonance Imaging, Humans, Male, Middle Aged, Neoplasm Grading, PI-RADSv2, Predictive Value of Tests, Prostate, Prostatic Neoplasms, Retrospective Studies, Sensitivity and Specificity
Date Added 2018/11/13 - 17:35:23
Date Modified 2019/05/21 - 13:44:42


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés